Assessment of RE symptoms in Japan and evaluation of treatment satisfactio
Not Applicable
- Conditions
- Reflux esophagitis
- Registration Number
- JPRN-UMIN000021993
- Lead Sponsor
- AstraZeneca K.K. Medical
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 2000
Inclusion Criteria
1.Patients who give informed consent through the internet.
2.Patients who are 20 years of age and older at the time of receiving IC.
3.Patients who are diagnosed as a RE by doctors
4. Patients who are administered one or more drugs prescribed by doctors among the followings used to treat RE for at least more than four weeks to make heartburn and acid reflux disappear or to achieve lasting remission.
Exclusion Criteria
Subjects suspected of poor capability follow instructions of the survey.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The appropriate multivariate regression model is developed by using the treatment satisfaction questionnaire (TSQ) score as the response variable, by using the baseline characteristics and the degree (severity or frequency) of RE related subjective symptoms as the explanatory variables. Furthermore, the coefficient of determination and the standardized regression coefficient of that model are calculated.
- Secondary Outcome Measures
Name Time Method The appropriate multivariate regression model is developed by using the satisfaction score which is TSQ's sub-category as the response variable, by using the other sub-categories, the baseline characteristics and the degree of RE related subjective symptoms as the explanatory variables. Furthermore, the coefficient of determination and the standardized regression coefficient of that model are calculated.